{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:08:29Z","timestamp":1773929309608,"version":"3.50.1"},"reference-count":39,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2021,9,24]]},"DOI":"10.1253\/circj.cj-21-0221","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T22:06:57Z","timestamp":1626732417000},"page":"1770-1778","source":"Crossref","is-referenced-by-count":17,"title":["Renal Dysfunction as a Predictor of Slow-Flow\/No-Reflow Phenomenon and Impaired ST Segment Resolution After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction With Initial Thrombolysis in Myocardial Infarction Grade 0"],"prefix":"10.1253","volume":"85","author":[{"given":"Takahiko","family":"Kai","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fujieda Municipal General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujieda Municipal General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuomi","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujieda Municipal General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujieda Municipal General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujieda Municipal General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujieda Municipal General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujieda Municipal General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. <i>N Engl J Med<\/i> 1993; 329: 1615\u20131622.","DOI":"10.1056\/NEJM199311253292204"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rezkalla SH, Kloner RA. Coronary no reflow phenomenon: From the experimental laboratory to the cardiac catheterization laboratory. <i>Catheter Cardiovasc Interv<\/i> 2008; 72: 950\u2013957.","DOI":"10.1002\/ccd.21715"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ronen J, Thierry C, Geoffrey P, Alexander D, Bradley HS. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. <i>Circulation<\/i> 2008; 117: 3152\u20133156.","DOI":"10.1161\/CIRCULATIONAHA.107.742312"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dong-bao L, Qi H, Zhi L, Shan W, Weiying J. Predictors and long-term prognosis of angiographic slow\/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevation acute myocardial infarction. <i>Clin Cardiol<\/i> 2010; 33: E7\u2013E12.","DOI":"10.1002\/clc.20634"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kousei O, Shuntaro I, Hisaki K, Kenichi Y, Naoki I, Kiyotaka O, et al. Impact of culprit plaque volume and composition on myocardial microcirculation following primary angioplasty in patients with ST-segment elevation myocardial infarction: Vitrual histology intravascular ultrasound analysis. <i>Int J Cardiol<\/i> 2013; 167: 1000\u20131005.","DOI":"10.1016\/j.ijcard.2012.03.079"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schr\u00f6der R, Dissmann R, Br\u00fcggemann T, Wegscheider K, Linderer T, Tebbe U, et al. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction. <i>J Am Coll Cardiol<\/i> 1994; 24: 384\u2013391.","DOI":"10.1016\/0735-1097(94)90292-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fajar JK, Heriansyah T, Rohman MS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis. <i>Indian Heart J<\/i> 2018; 70(Suppl 3): S406\u2013S418.","DOI":"10.1016\/j.ihj.2018.01.032"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I findings. <i>N Engl J Med<\/i> 1985; 312: 932\u2013936.","DOI":"10.1056\/NEJM198504043121437"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schr\u00f6der R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. <i>Circulation<\/i> 2004; 110: e506\u2013e510.","DOI":"10.1161\/01.CIR.0000147778.05979.E6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. <i>Am J Kidney Dis<\/i> 2009; 53: 982\u2013992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zeymer U, Schr\u00f6der R, Machnig T, Neuhaus KL. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. <i>Am Heart J<\/i> 2003; 146: 686\u2013691.","DOI":"10.1016\/S0002-8703(03)00326-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wegscheider K, Neuhaus KL, Dissmann R, Tebbe U, Zeymer R, Schr\u00f6der R. Prognostic significance of ST segment change in acute myocardial infarct. <i>Herz<\/i> 1999; 24: 378\u2013388.","DOI":"10.1007\/BF03043929"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Schr\u00f6der K, Zeymer U, Wegschneider W, Schr\u00f6der R. Prediction of outcome in ST elevation myocardial infarction by the extent of ST segment deviation recovery: Which method is best? <i>Z Kardiol<\/i> 2004; 93: 595\u2013604.","DOI":"10.1007\/s00392-004-0102-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. De Luca G, van\u2019t Hof AW, de Boer MJ, Ottervanger JP, Hoorntje JC, Gosselink AT, et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. <i>Eur Heart J<\/i> 2004; 25: 1009\u20131013.","DOI":"10.1016\/j.ehj.2004.03.021"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. L\u00f8nborg J, Holmvang L, Kelb\u00e6k H, Vejlstrup N, J\u00f8rgensen E, Helqvist S, et al. ST-segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance. <i>Am Heart J<\/i> 2010; 160: 1085\u20131091.","DOI":"10.1016\/j.ahj.2010.09.026"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Brener SJ, Dizon JM, Mehran R, Guerchicoff A, Lansky AJ, Farkouh M, et al. Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: Analysis from the HORIZONS-AMI trial. <i>Am Heart J<\/i> 2013; 166: 676\u2013683.","DOI":"10.1016\/j.ahj.2013.07.025"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Giampaolo N, Giancarla S, Amir L, Filippo C. Coronary microvascular obstruction in acute myocardial infarction. <i>Eur Heart J<\/i> 2016; 37: 1024\u20131033.","DOI":"10.1093\/eurheartj\/ehv484"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Giampaolo N, Francesco B, Leonarda G, Filippo C. Myocardial no-reflow in humans. <i>J Am Coll Cardiol<\/i> 2009; 54: 281\u2013292.","DOI":"10.1016\/j.jacc.2009.03.054"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wong DT, Puri R, Richardson JD, Worthley MI, Worthley SG. Myocardial \u2018no-reflow\u2019: Diagnosis, pathophysiology and treatment. <i>Int J Cardiol<\/i> 2013; 167: 1798\u20131806.","DOI":"10.1016\/j.ijcard.2012.12.049"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. <i>JACC<\/i> 2002; 39: 1113\u20131119.","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kurtul A, Murat SN, Yarlioglues M, Duran M, Celik IE, Kilic A. Mild to moderate renal impairment is associated with no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. <i>Angiology<\/i> 2015; 66: 644\u2013651.","DOI":"10.1177\/0003319714546738"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: A scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. <i>Circulation<\/i> 2006; 114: 1321\u20131341.","DOI":"10.1161\/CIRCULATIONAHA.106.177276"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chade AR, Brosh D, Higano ST, Lennon RJ, Lerman LO, Lerman A. Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. <i>Kidney Int<\/i> 2006; 69: 266\u2013271.","DOI":"10.1038\/sj.ki.5000031"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mohandas R, Segal MS, Huo T, Handberg EM, Petersen JW, Johnson BD, et al. Renal function and coronary microvascular dysfunction in women with symptoms\/signs of ischemia. <i>PLoS One<\/i> 2015; 10: e0125374.","DOI":"10.1371\/journal.pone.0125374"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hideki F, Keiji K, Shinichi N. Characteristics of coronary artery disease in chronic kidney disease. <i>Clin Exp Nephrol<\/i> 2019; 23: 725\u2013732.","DOI":"10.1007\/s10157-019-01718-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Guasti L, Dentali F, Castiglioni L, Maroni L, Marino F, Squizzato A, et al. Neutrophils and clinical outcomes in patients with acute coronary syndromes and\/or cardiac revascularization: A systematic review on more than 34 000 subjects. <i>Thromb Haemost<\/i> 2011; 106: 591\u2013599.","DOI":"10.1160\/TH11-02-0096"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. <i>Am J Cardiol<\/i> 2008; 102: 653\u2013657.","DOI":"10.1016\/j.amjcard.2008.05.006"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. <i>Am J Cardiol<\/i> 2011; 107: 433\u2013438.","DOI":"10.1016\/j.amjcard.2010.09.039"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil\/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. <i>Am J Cardiol<\/i> 2010; 105: 186\u2013191.","DOI":"10.1016\/j.amjcard.2009.09.007"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. <i>Am J Cardiol<\/i> 2013; 111: 636\u2013642.","DOI":"10.1016\/j.amjcard.2012.11.012"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Machado GP, Araujo GN, Carpes CK, Lech M, Mariani S, Valle FH, et al. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. <i>Atherosclerosis<\/i> 2018; 274: 212\u2013217.","DOI":"10.1016\/j.atherosclerosis.2018.05.022"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sevencan NO, Ozkan AE. Associations between neutrophil\/lymphocyte ratio, platelet\/lymphocyte ratio, albuminuria and uric acid and the estimated glomerular filtration rate in hypertensive patients with chronic kidney disease stages 1\u20133. <i>Arch Med Sci<\/i> 2019; 15: 1232\u20131239.","DOI":"10.5114\/aoms.2018.76262"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Falk E. Pathogenesis of atherosclerosis. <i>J Am Coll Cardiol<\/i> 2006; 47(Suppl): C7\u2013C12.","DOI":"10.1016\/j.jacc.2005.09.068"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Korniluk A, Koper-Lenkiewicz OM, Kami\u0144ska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): New perspectives for an old marker in the course and prognosis of inflammatory conditions. <i>Mediators Inflamn<\/i> 2019; 2019: 9213074.","DOI":"10.1155\/2019\/9213074"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. <i>J Am Coll Cardiol<\/i> 2005; 46: 284\u2013290.","DOI":"10.1016\/j.jacc.2005.03.065"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Verdoia M, Barbieri L, Schaffer A, Bellomo G, Marino P, De Luca G. Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study. <i>Thromb Res<\/i> 2016; 141: 139\u2013144.","DOI":"10.1016\/j.thromres.2016.03.018"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Soeda T, Higuma T, Abe N, Yamada M, Yokoyama H, Shibutani S, et al. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture. <i>Eur Heart J Cardiovasc Imaging<\/i> 2017; 18: 103\u2013110.","DOI":"10.1093\/ehjci\/jev341"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kato K, Yonetsu T, Jia H, Abtahian F, Vergallo R, Hu S, et al. Nonculprit coronary plaque characteristics of chronic kidney disease. <i>Circ Cardiovasc Imaging<\/i> 2013; 6: 448\u2013456.","DOI":"10.1161\/CIRCIMAGING.112.000165"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Baber U, Stone GW, Weisz G, Moreno P, Dangas G, Maehara A, et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. <i>JACC Cardiovasc Imaging<\/i> 2012; 5(Suppl): S53\u2013S61.","DOI":"10.1016\/j.jcmg.2011.12.008"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/10\/85_CJ-21-0221\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T03:59:36Z","timestamp":1632542376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/10\/85_CJ-21-0221\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-21-0221","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"CJ-21-0221"}}